Successful Integrase Inhibitor-Based Highly Active Antiretroviral Therapy for a Multidrug-Class-Resistant HIV Type 1 Group O-Infected Patient in Cameroon-Reference-Cited by-同舟云学术

Successful Integrase Inhibitor-Based Highly Active Antiretroviral Therapy for a Multidrug-Class-Resistant HIV Type 1 Group O-Infected Patient in Cameroon

Published:2013-01 Issue:1 Volume:29 Page:1-3
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

Aghokeng Avelin F.¹²,Kouanfack Charles³,Peeters Martine²,Mpoudi-Ngole Eitel,Delaporte Eric²

Affiliation:

1. Virology Laboratory CREMER/IMPM/IRD, Yaoundé, Cameroon.

2. UMI 233 TransVIHMI, Institut de Recherche pour le Développement (IRD), University Montpellier 1, Montpellier, France.

3. Central Hospital, Yaoundé, Cameroon.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/aid.2012.0196

Reference11 articles.

1. The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings

2. Confirmation of Putative HIV-1 Group P in Cameroon

3. HIV-1 Group O Infection in Cameroon, 1986 to 1998

4. Impact of HIV-1 Group O Genetic Diversity on Genotypic Resistance Interpretation by Algorithms Designed for HIV-1 Group M

5. Inaccurate Diagnosis of HIV-1 Group M and O Is a Key Challenge for Ongoing Universal Access to Antiretroviral Treatment and HIV Prevention in Cameroon

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV-1 Non-Group M Strains and ART;Viruses;2023-03-17

2. HIV-1 integrase resistance associated mutations and the use of dolutegravir in Sub-Saharan Africa: A systematic review and meta-analysis;PLOS Global Public Health;2022-10-11

3. First case of Dolutegravir and Darunavir/r multi drug-resistant HIV-1 in Cameroon following exposure to Raltegravir: lessons and implications in the era of transition to Dolutegravir-based regimens;Antimicrobial Resistance & Infection Control;2020-08-26

4. Virological response to integrase strand transfer inhibitor-based antiretroviral combinations in HIV-1 group O-infected patients;AIDS;2019-07-01

5. Human Immunodeficiency Virus Type 1 Group O Infection in France: Clinical Features and Immunovirological Response to Antiretrovirals;Clinical Infectious Diseases;2017-12-21